scholarly article | Q13442814 |
P2093 | author name string | Darius R Mehregan | |
Bahar Dasgeb | |||
Tarana M Mohammadi | |||
P2860 | cites work | Immunohistochemistry in ocular carcinomas | Q42523700 |
Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer | Q46094231 | ||
Nuclear signalling by tumour-associated antigen EpCAM | Q24315870 | ||
EpCAM (CD326) finding its role in cancer | Q24653692 | ||
Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study | Q28202724 | ||
Frequent EpCam protein expression in human carcinomas | Q28241018 | ||
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer | Q34994161 | ||
Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581 | Q35170266 | ||
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. | Q36613499 | ||
Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin | Q38463991 | ||
Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens | Q38552423 | ||
Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. | Q39641175 | ||
Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies | Q41670912 | ||
Immunohistochemical demonstration of D2-40 in basal cell carcinomas of the skin | Q42437124 | ||
Anti-human epithelial antigen (Ber-EP4) helps define basal cell carcinoma masked by inflammation | Q42447865 | ||
Trichoadenoma of Nikolowski is a distinct neoplasm within the spectrum of follicular tumors | Q42466574 | ||
Ber-EP4-positive phenotype differentiates actinic keratosis from superficial basal cell carcinoma | Q42488185 | ||
Sebaceous carcinoma: an immunohistochemical reappraisal. | Q42491883 | ||
Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis | Q42501421 | ||
Ber-EP4 is a useful marker for follicular germinative cell differentiation of cutaneous epithelial neoplasms | Q42501521 | ||
Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin | Q42502694 | ||
Ber-EP4 immunoreactivity in normal skin and cutaneous neoplasms | Q42513692 | ||
Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma | Q42519056 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 7-11 | |
P577 | publication date | 2013-06-25 | |
P1433 | published in | Biomarkers in cancer | Q27723062 |
P1476 | title | Use of Ber-EP4 and Epithelial Specific Antigen to Differentiate Clinical Simulators of Basal Cell Carcinoma | |
P478 | volume | 5 |
Q64243610 | Applications of SNAP-tag technology in skin cancer therapy |
Q47917911 | Automated selection of aptamers against cholangiocarcinoma cells on an integrated microfluidic platform. |
Q57821304 | Basal Cell Carcinoma Arises from Interfollicular Layer of Epidermis |
Q55289041 | Cutaneous Basal Cell Carcinoma with Lymph Node and Pulmonary Metastases. |
Q92379087 | Endoscopic features and associated histology of an basaloid squamous cell carcinoma of the esophagus at the very early stage |
Q38757209 | Implementation of fluorescence confocal mosaicking microscopy by "early adopter" Mohs surgeons and dermatologists: recent progress |
Q49787188 | The Use of BEREP4 Immunohistochemistry Staining for Detection of Basal Cell Carcinoma. |
Q35139605 | The importance of cytokeratin 19 expression in the differentiation of Basal cell carcinoma and trichoepithelioma |
Search more.